Oxford Biomedica Signs LSA With Arcellx, Extends Deal With Novartis - Quick Facts
13/12 08:51
(RTTNews) - Oxford Biomedica plc (OXB.L), a gene and cell therapy group, Monday said it has signed a new Licence and Supply Agreement or LSA with Arcellx, Inc. for LentiVector Platform for CAR-T Therapeutics....